Log In
BCIQ
Print this Print this
 

OMS201

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionAnti-inflammatory agent combined with a smooth muscle relaxant
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard Indication Inflammation (unspecified)
Indication DetailsInhibit surgically-induced inflammation, pain and smooth muscle spasm in patients undergoing ureteroscopy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today